Algorae Pharmaceuticals
Algorae Pharmaceuticals Limited focuses on the development and commercialization of innovative pharmaceuticals and biotechnology products. The company leverages cutting-edge research to address unmet medical needs across various therapeutic areas. Its market position is bolstered by a robust pipeline of drugs that target specific industry demands, making it a key player in pharmaceutical innovation.
Short position
Algorae Pharmaceuticals (ASX:1AI) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 16,823 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. 1AI is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Algorae Pharmaceuticals (1AI) short interest history
1AI Short Interest History
- 30-day change
- 0.00pp
- 90-day change
- 0.00pp
- 1-year change
- +0.00pp
- All-time high
- 0.00% (April 2026)
- All-time low
- 0.00% (February 2024)
Is 1AI heavily shorted?
Not especially: 0.00% short interest is modest by ASX standards, ranking #669 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has 1AI's short interest changed recently?
Over the past 30 days Algorae Pharmaceuticals's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.
What is the highest 1AI's short interest has been?
Since 2024, Algorae Pharmaceuticals's short interest peaked at 0.00% in April 2026 and bottomed at 0.00% in February 2024.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2024. See our methodology.